Global Biosimilar Monoclonal Antibodies Competitive Landscape Professional Research Report 2025
Research Summary
Biosimilar monoclonal antibodies are therapeutic proteins that are highly similar to existing monoclonal antibodies, which are designed to target specific disease-causing molecules in the body. Biosimilar monoclonal antibodies are created through a complex manufacturing process that involves the use of living cells to produce proteins that mimic the structure and function of the original antibody. These biosimilars undergo rigorous testing to demonstrate similarity in terms of efficacy, safety, and quality compared to the reference monoclonal antibody. They offer the potential for more affordable and accessible treatment options for patients, as they can be approved as alternatives to expensive brand-name monoclonal antibodies once their patents expire.
According to DIResearch's in-depth investigation and research, the global Biosimilar Monoclonal Antibodies market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.
The major global manufacturers of Biosimilar Monoclonal Antibodies include Biocon, Accord Healthcare, AET Biotech, Amgen, Celltrion, Reddy＇s Laboratories, Hospira, 3SBio, Allergan, Alvartis etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Biosimilar Monoclonal Antibodies. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Biosimilar Monoclonal Antibodies market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Biosimilar Monoclonal Antibodies market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Biosimilar Monoclonal Antibodies industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Biosimilar Monoclonal Antibodies Include:
Biocon
Accord Healthcare
AET Biotech
Amgen
Celltrion
Reddy＇s Laboratories
Hospira
3SBio
Allergan
Alvartis
Biosimilar Monoclonal Antibodies Product Segment Include:
Limited Dilution Method
Micromanipulation
Soft Agar Plate Method
Others
Biosimilar Monoclonal Antibodies Product Application Include:
Chronic & Autoimmune Diseases
Oncology
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Biosimilar Monoclonal Antibodies Industry PESTEL Analysis
Chapter 3: Global Biosimilar Monoclonal Antibodies Industry Porter’s Five Forces Analysis
Chapter 4: Global Biosimilar Monoclonal Antibodies Major Regional Market Size and Forecast Analysis
Chapter 5: Global Biosimilar Monoclonal Antibodies Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Passenger Biosimilar Monoclonal Antibodies Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Biosimilar Monoclonal Antibodies Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Biosimilar Monoclonal Antibodies Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Biosimilar Monoclonal Antibodies Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Biosimilar Monoclonal Antibodies Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Biosimilar Monoclonal Antibodies Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Biosimilar Monoclonal Antibodies Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
- 1 Biosimilar Monoclonal Antibodies Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Biosimilar Monoclonal Antibodies Product by Type
- 1.2.1 Limited Dilution Method
- 1.2.2 Micromanipulation
- 1.2.3 Soft Agar Plate Method
- 1.2.4 Others
- 1.3 Biosimilar Monoclonal Antibodies Product by Application
- 1.3.1 Chronic & Autoimmune Diseases
- 1.3.2 Oncology
- 1.3.3 Others
- 1.4 Global Biosimilar Monoclonal Antibodies Market Size Analysis (2020-2032)
- 1.5 Biosimilar Monoclonal Antibodies Market Development Status and Trends
- 1.5.1 Biosimilar Monoclonal Antibodies Industry Development Status Analysis
- 1.5.2 Biosimilar Monoclonal Antibodies Industry Development Trends Analysis
- 2 Biosimilar Monoclonal Antibodies Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Biosimilar Monoclonal Antibodies Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Biosimilar Monoclonal Antibodies Market Analysis by Regions
- 4.1 Biosimilar Monoclonal Antibodies Overall Market: 2024 VS 2025 VS 2032
- 4.2 Global Biosimilar Monoclonal Antibodies Revenue and Forecast Analysis (2020-2032)
- 4.2.1 Global Biosimilar Monoclonal Antibodies Revenue and Market Share by Region (2020-2025)
- 4.2.2 Global Biosimilar Monoclonal Antibodies Revenue Forecast by Region (2026-2032)
- 5 Global Biosimilar Monoclonal Antibodies Market Size by Type and Application
- 5.1 Global Biosimilar Monoclonal Antibodies Market Size by Type (2020-2032)
- 5.2 Global Biosimilar Monoclonal Antibodies Market Size by Application (2020-2032)
- 6 North America
- 6.1 North America Biosimilar Monoclonal Antibodies Market Size and Growth Rate Analysis (2020-2032)
- 6.2 North America Key Manufacturers Analysis
- 6.3 North America Biosimilar Monoclonal Antibodies Market Size by Type
- 6.4 North America Biosimilar Monoclonal Antibodies Market Size by Application
- 6.5 North America Biosimilar Monoclonal Antibodies Market Size by Country
- 6.5.1 US
- 6.5.2 Canada
- 7 Europe
- 7.1 Europe Biosimilar Monoclonal Antibodies Market Size and Growth Rate Analysis (2020-2032)
- 7.2 Europe Key Manufacturers Analysis
- 7.3 Europe Biosimilar Monoclonal Antibodies Market Size by Type
- 7.4 Europe Biosimilar Monoclonal Antibodies Market Size by Application
- 7.5 Europe Biosimilar Monoclonal Antibodies Market Size by Country
- 7.5.1 Germany
- 7.5.2 France
- 7.5.3 United Kingdom
- 7.5.4 Italy
- 7.5.5 Spain
- 7.5.6 Benelux
- 8 China
- 8.1 China Biosimilar Monoclonal Antibodies Market Size and Growth Rate Analysis (2020-2032)
- 8.2 China Key Manufacturers Analysis
- 8.3 China Biosimilar Monoclonal Antibodies Market Size by Type
- 8.4 China Biosimilar Monoclonal Antibodies Market Size by Application
- 9 APAC (excl. China)
- 9.1 APAC (excl. China) Biosimilar Monoclonal Antibodies Market Size and Growth Rate Analysis (2020-2032)
- 9.2 APAC (excl. China) Key Manufacturers Analysis
- 9.3 APAC (excl. China) Biosimilar Monoclonal Antibodies Market Size by Type
- 9.4 APAC (excl. China) Biosimilar Monoclonal Antibodies Market Size by Application
- 9.5 APAC (excl. China) Biosimilar Monoclonal Antibodies Market Size by Country
- 9.5.1 Japan
- 9.5.2 South Korea
- 9.5.3 India
- 9.5.4 Australia
- 9.5.5 Southeast Asia
- 10 Latin America
- 10.1 Latin America Biosimilar Monoclonal Antibodies Market Size and Growth Rate Analysis (2020-2032)
- 10.2 Latin America Key Manufacturers Analysis
- 10.3 Latin America Biosimilar Monoclonal Antibodies Market Size by Type
- 10.4 Latin America Biosimilar Monoclonal Antibodies Market Size by Application
- 10.5 Latin America Biosimilar Monoclonal Antibodies Market Size by Country
- 10.5.1 Mexico
- 10.5.2 Brazil
- 11 Middle East & Africa
- 11.1 Middle East & Africa Biosimilar Monoclonal Antibodies Market Size and Growth Rate Analysis (2020-2032)
- 11.2 Middle East & Africa Key Manufacturers Analysis
- 11.3 Middle East & Africa Biosimilar Monoclonal Antibodies Market Size by Type
- 11.4 Middle East & Africa Biosimilar Monoclonal Antibodies Market Size by Application
- 11.5 Middle East & Africa Biosimilar Monoclonal Antibodies Market Size by Country
- 11.5.1 Saudi Arabia
- 11.5.2 South Africa
- 12 Competition by Manufacturers
- 12.1 Global Biosimilar Monoclonal Antibodies Market Revenue by Key Manufacturers (2021-2025)
- 12.2 Biosimilar Monoclonal Antibodies Competitive Landscape Analysis and Market Dynamic
- 12.2.1 Biosimilar Monoclonal Antibodies Competitive Landscape Analysis
- 12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales
- 12.2.3 Market Dynamic
- 13 Key Companies Analysis
- 13.1 Biocon
- 13.1.1 Biocon Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.1.2 Biocon Biosimilar Monoclonal Antibodies Product Portfolio
- 13.1.3 Biocon Biosimilar Monoclonal Antibodies Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.2 Accord Healthcare
- 13.2.1 Accord Healthcare Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.2.2 Accord Healthcare Biosimilar Monoclonal Antibodies Product Portfolio
- 13.2.3 Accord Healthcare Biosimilar Monoclonal Antibodies Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.3 AET Biotech
- 13.3.1 AET Biotech Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.3.2 AET Biotech Biosimilar Monoclonal Antibodies Product Portfolio
- 13.3.3 AET Biotech Biosimilar Monoclonal Antibodies Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.4 Amgen
- 13.4.1 Amgen Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.4.2 Amgen Biosimilar Monoclonal Antibodies Product Portfolio
- 13.4.3 Amgen Biosimilar Monoclonal Antibodies Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.5 Celltrion
- 13.5.1 Celltrion Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.5.2 Celltrion Biosimilar Monoclonal Antibodies Product Portfolio
- 13.5.3 Celltrion Biosimilar Monoclonal Antibodies Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.6 Reddy＇s Laboratories
- 13.6.1 Reddy＇s Laboratories Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.6.2 Reddy＇s Laboratories Biosimilar Monoclonal Antibodies Product Portfolio
- 13.6.3 Reddy＇s Laboratories Biosimilar Monoclonal Antibodies Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.7 Hospira
- 13.7.1 Hospira Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.7.2 Hospira Biosimilar Monoclonal Antibodies Product Portfolio
- 13.7.3 Hospira Biosimilar Monoclonal Antibodies Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.8 3SBio
- 13.8.1 3SBio Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.8.2 3SBio Biosimilar Monoclonal Antibodies Product Portfolio
- 13.8.3 3SBio Biosimilar Monoclonal Antibodies Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.9 Allergan
- 13.9.1 Allergan Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.9.2 Allergan Biosimilar Monoclonal Antibodies Product Portfolio
- 13.9.3 Allergan Biosimilar Monoclonal Antibodies Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.10 Alvartis
- 13.10.1 Alvartis Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.10.2 Alvartis Biosimilar Monoclonal Antibodies Product Portfolio
- 13.10.3 Alvartis Biosimilar Monoclonal Antibodies Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 14 Industry Chain Analysis
- 14.1 Biosimilar Monoclonal Antibodies Industry Chain Analysis
- 14.2 Biosimilar Monoclonal Antibodies Industry Raw Material and Suppliers Analysis
- 14.2.1 Biosimilar Monoclonal Antibodies Key Raw Material Supply Analysis
- 14.2.2 Raw Material Suppliers and Contact Information
- 14.3 Biosimilar Monoclonal Antibodies Typical Downstream Customers
- 14.4 Biosimilar Monoclonal Antibodies Sales Channel Analysis
- 15 Research Findings and Conclusion
- 16 Methodology and Data Source
- 16.1 Methodology/Research Approach
- 16.2 Research Scope
- 16.3 Benchmarks and Assumptions
- 16.4 Date Source
- 16.4.1 Primary Sources
- 16.4.2 Secondary Sources
- 16.5 Data Cross Validation
- 16.6 Disclaimer
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook